Has James Irvine, MD received payments from drug or device companies?

Yes. Drug and device makers reported $17,395 in general payments to James Irvine, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Irvine, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Irvine, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Irvine, MD

Orthopaedic Surgery · McKeesport, PANPI 1053673038

Payments from drug & device makers

$17,395in general payments, 2019–2025

Across 31 payments — averaging $561.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$12K
Arthrex$4K
Mid-atlantic Surgical Systems, LLC$1K
Zimmer Biomet$117
Linvatec Corporation$37
Gotham Surgical Solutions & Devices, Inc.$34
plus $23 from 1 others

What the payments were for

Travel & lodging$1,66110%
Food & beverage$6964%
Education$15,03886%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	7	$12,290
Arthrex	17	$3,656
Mid-atlantic Surgical Systems, LLC	3	$1,238
Zimmer Biomet	1	$117
Linvatec Corporation	1	$37
Gotham Surgical Solutions & Devices, Inc.	1	$34
Johnson & Johnson	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,395 in reported general payments places this provider in the 75th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$93,746

Medicare patients

401

Services billed

2,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	28	$702
Naproxen	48	$363
Methylprednisolone	40	$194
Meloxicam	21	$36

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in McKeesport

William HozackBensalem$10.6M
Jess LonnerBryn Mawr$8.1M
Gerald WilliamsBryn Mawr$6.8M
Mark LazarusBensalem$6.4M
John FenlinPhiladelphia$5.9M
Peter SharkeyKing Of Prussia$5.7M
Selene ParekhBensalem$4.9M
Alexander VaccaroPhiladelphia$4.5M
Joseph AbboudPhiladelphia$4.1M
Jonathan GarinoMalvern$3.8M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →